Similarly, we report that the level of GBP1 mRNA expression detected by RNA-seq correlates with better 5-year overall survival in the TCGA cohort consisting of 373 EOC samples, which include cystic, mucinous, and serous ovarian cancers [38]. This evidence concerns the gene GBP1 and ovarian serous adenocarcinoma.